The analysis showed that expression levels of YTHDF1 (p < 0.05), YTHDF2 (p < 0.05) and YTHDF3 (p < 0.05) were significantly upregulated in HCC patients (Figure 1B). Here, YTHDF2 is linked to hepatocellular carcinoma.